Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany

Eidt-Koch D, Mittendorf T, Greiner W (2009)
BMC Pediatrics 9(1).

Download
OA
Journal Article | Published | English
Author
; ;
Abstract
Background: Quality of life is recognized as an important additional outcome measure in clinical trials and health economic evaluations. The EQ-5D is an important generic health outcome instrument often used for economic evaluations as a complement with disease-specific outcome measures. In this study quality of life data was assessed using the EQ-5D-Y (new EQ-5D version for children and adolescents) and the Cystic Fibrosis Questionnaire (CFQ). The objective of the study is to evaluate the cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. Methods: In 2006 a multi-centre study was conducted in four cystic fibrosis centres in Germany. Quality of life data from 96 patients between eight and seventeen years was collected using the EQ-5D-Y as a generic outcome instrument and the Cystic Fibrosis Questionnaire (CFQ) as a disease-specific instrument. Results of both instruments were compared by statistical analyses using Spearman's rank correlations. Results: 44.6% of the patients stated that they had no problems in any of the EQ-5D-Y dimensions. Several low to high correlations between separate dimensions and the visual analogue scale of the EQ-5D-Y and the different scales of the CFQ for children, their parents and adolescents can be presented in this paper. Looking at the five EQ-5D-Y dimensions the highest correlation (rS = 0.625, p = 0.01) was found between the dimension 'mobility' and the CFQ scale 'physical functioning' in adolescent patients. The overall highest correlation was found between the 'subjective health perception' and the visual analogue scale (rS = 0.744, p = 0.01) in adolescent patients older than 13 years. Conclusion: The EQ-5D-Y can be considered a cross-sectional valid generic health outcome instrument which reflects differences in health according to the progression of the life-long chronic disease cystic fibrosis.
Publishing Year
ISSN
PUB-ID

Cite this

Eidt-Koch D, Mittendorf T, Greiner W. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. BMC Pediatrics. 2009;9(1).
Eidt-Koch, D., Mittendorf, T., & Greiner, W. (2009). Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. BMC Pediatrics, 9(1).
Eidt-Koch, D., Mittendorf, T., and Greiner, W. (2009). Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. BMC Pediatrics 9.
Eidt-Koch, D., Mittendorf, T., & Greiner, W., 2009. Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. BMC Pediatrics, 9(1).
D. Eidt-Koch, T. Mittendorf, and W. Greiner, “Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany”, BMC Pediatrics, vol. 9, 2009.
Eidt-Koch, D., Mittendorf, T., Greiner, W.: Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany. BMC Pediatrics. 9, (2009).
Eidt-Koch, Daniela, Mittendorf, Thomas, and Greiner, Wolfgang. “Cross-sectional validity of the EQ-5D-Y as a generic health outcome instrument in children and adolescents with cystic fibrosis in Germany”. BMC Pediatrics 9.1 (2009).
Main File(s)
File Name
Access Level
OA Open Access

This data publication is cited in the following publications:
This publication cites the following data publications:

11 Citations in Europe PMC

Data provided by Europe PubMed Central.

Social and economic costs and health-related quality of life in non-institutionalised patients with cystic fibrosis in the United Kingdom.
Angelis A, Kanavos P, Lopez-Bastida J, Linertova R, Nicod E, Serrano-Aguilar P; BURQOL-RD Research Network, Serrano-Aguilar P, Linertova R, Lopez-Bastida J, Oliva-Moreno J, Posada de la Paz M, Perez MH, Abaitua I, Taruscio D, Kodra Y, Schieppati A, Stefanov R, Iskrov G, Gulacsi L, Pentek M, de Enfermedades Raras FE, de Vega Garcia RS, Delgado C, Kanavos P, Angelis A, Nicod E, von der Schulenburg J, Kuhlmann A, Persson U, Ghatnekar O, Chevreul K, Brigham K, Fattore G, Cavazza M., BMC Health Serv Res 15(), 2015
PMID: 26416027
The Value Adults Place on Child Health and Functional Status.
Craig BM, Brown DS, Reeve BB., Value Health 18(4), 2015
PMID: 26091599
Can adult weights be used to value child health states? Testing the influence of perspective in valuing EQ-5D-Y.
Kind P, Klose K, Gusi N, Olivares PR, Greiner W., Qual Life Res 24(10), 2015
PMID: 25894060
Measuring health-related quality of life with the EQ-5D-Y instrument in children and adolescents with asthma.
Bergfors S, Astrom M, Burstrom K, Egmar AC., Acta Paediatr. 104(2), 2015
PMID: 25393977
Mapping EQ-5D utility scores from the PedsQL™ generic core scales.
Khan KA, Petrou S, Rivero-Arias O, Walters SJ, Boyle SE., Pharmacoeconomics 32(7), 2014
PMID: 24715604
How about your peers? Cystic fibrosis questionnaire data from healthy children and adolescents.
Tibosch MM, Sintnicolaas CJ, Peters JB, Merkus PJ, Yntema JB, Verhaak CM, Vercoulen JH., BMC Pediatr 11(), 2011
PMID: 21989260

11 References

Data provided by Europe PubMed Central.

Quality of life – evaluation criteria for children with chronic conditions in medical care
Bullinger M, Schmidt S, Petersen C, Ravens-Sieberer U., 2006

Stern M, Sens B, Wiedemann B, Busse O, Damm G, Wenzlaff P., 2009
Validating the EQ-5D with time trade off for the German population.
Greiner W, Claes C, Busschbach JJ, von der Schulenburg JM., Eur J Health Econ 6(2), 2005
PMID: 19787848
Translation and testing of a Spanish Child-Friendly version of EQ-5D and the appropriateness of the EQ-5D
Gusi N, Badía X, Herdman M, Olvares P., 2006
Translation and testing of an Italian Child-Friendly version of EQ-5D
Scalone L, Cavrini G, Pacelli B, Mattivi A., 2006
The Contribution of lexical analyses of the wording in cognitive interviews during the CF-EQ-5D italian translation
Tomasetto C, Matteucci MC, Selleri P, Cavrini G., 2006
Age-appropriateness of the EQ-5D adult and child-friendly version – Testing the feasibility, reliability and validity in children and adolescents
Wille N, Ravens-Sieberer U., 2006
Establishing definitions of the concepts included in CF-EQ-5D – A revision of the "Definition of EQ-5D concepts" for adults
Wille N, Ravens-Sieberer U., 2006
Proposal on a core set of instruments for validation of the international child-friendly EQ-5D
Wille N, Ravens-Sieberer U., 2006
The concurrent validity of the Child Friendly version of the EQ-5D when used with high school English speaking children in South Africa
Jelsma J, Coppez P, Jehosofat T, Lenders C., 2006
The revised German Cystic Fibrosis Questionnaire: validation of a disease-specific health-related quality of life instrument.
Wenninger K, Aussage P, Wahn U, Staab D; German Cystic Fibrosis Questionnaire study group., Qual Life Res 12(1), 2003
PMID: 12625520

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 19715563
PubMed | Europe PMC

Search this title in

Google Scholar